Literature DB >> 23216904

ROS-generating oxidases Nox1 and Nox4 contribute to oncogenic Ras-induced premature senescence.

Ryo Kodama1, Masayoshi Kato, Shuichi Furuta, Shouta Ueno, Yugen Zhang, Kuniharu Matsuno, Chihiro Yabe-Nishimura, Eiji Tanaka, Tohru Kamata.   

Abstract

Activated oncogenes induce premature cellular senescence, a permanent state of proliferative arrest in primary rodent and human fibroblasts. Recent studies suggest that generation of reactive oxygen species (ROS) is involved in oncogenic Ras-induced premature senescence. However, the signaling mechanism controlling this oxidant-mediated irreversible growth arrest is not fully understood. Here, we show that through the Ras/MEK pathway, Ras oncogene up-regulated the expression of superoxide-generating oxidases, Nox1 in rat REF52 cells and Nox4 in primary human lung TIG-3 cells, leading to an increase in intracellular level of ROS. Ablation of Nox1 and Nox4 by small interfering RNAs (siRNAs) blocked the RasV12 senescent phenotype including β-galactosidase activity, growth arrest and accumulation of tumor suppressors such as p53 and p16Ink4a. This suggests that Nox-generated ROS transduce senescence signals by activating the p53 and p16Ink4a pathway. Furthermore, Nox1 and Nox4 siRNAs inhibited both Ras-induced DNA damage response and p38MAPK activation, whereas overexpression of Nox1 and Nox4 alone was able to induce senescence. The involvement of Nox1 in Ras-induced senescence was also confirmed with embryonic fibroblasts derived from Nox1 knockout mice. Together, these findings suggest that Nox1- and Nox4-generated ROS play an important role in Ras-induced premature senescence, which may involve DNA damage response and p38MAPK signaling pathways.
© 2012 The Authors Genes to Cells © 2012 by the Molecular Biology Society of Japan and Wiley Publishing Asia Pty Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23216904     DOI: 10.1111/gtc.12015

Source DB:  PubMed          Journal:  Genes Cells        ISSN: 1356-9597            Impact factor:   1.891


  44 in total

Review 1.  ROS in gastrointestinal inflammation: Rescue Or Sabotage?

Authors:  G Aviello; U G Knaus
Journal:  Br J Pharmacol       Date:  2016-03-03       Impact factor: 8.739

Review 2.  NRF2 and the Hallmarks of Cancer.

Authors:  Montserrat Rojo de la Vega; Eli Chapman; Donna D Zhang
Journal:  Cancer Cell       Date:  2018-05-03       Impact factor: 31.743

3.  NADPH oxidase 4 is a critical mediator in Ataxia telangiectasia disease.

Authors:  Urbain Weyemi; Christophe E Redon; Towqir Aziz; Rohini Choudhuri; Daisuke Maeda; Palak R Parekh; Michael Y Bonner; Jack L Arbiser; William M Bonner
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-02       Impact factor: 11.205

Review 4.  Therapeutic potential of NADPH oxidase 1/4 inhibitors.

Authors:  G Teixeira; C Szyndralewiez; S Molango; S Carnesecchi; F Heitz; P Wiesel; J M Wood
Journal:  Br J Pharmacol       Date:  2016-07-14       Impact factor: 8.739

5.  Interferon gamma/NADPH oxidase defense system in immunity and cancer.

Authors:  Zdenek Hodny; Milan Reinis; Sona Hubackova; Pavla Vasicova; Jiri Bartek
Journal:  Oncoimmunology       Date:  2015-09-01       Impact factor: 8.110

6.  Changing T-cell enigma: cancer killing or cancer control?

Authors:  Thomas Wieder; Heidi Braumüller; Ellen Brenner; Lars Zender; Martin Röcken
Journal:  Cell Cycle       Date:  2013-08-26       Impact factor: 4.534

7.  Correction.

Authors: 
Journal:  Cancer Sci       Date:  2016-07       Impact factor: 6.716

8.  E2F transcription factor 1 regulates cellular and organismal senescence by inhibiting Forkhead box O transcription factors.

Authors:  Qi Xie; Shengyi Peng; Li Tao; Haihe Ruan; Yanglu Yang; Tie-Mei Li; Ursula Adams; Songshu Meng; Xiaolin Bi; Meng-Qiu Dong; Zengqiang Yuan
Journal:  J Biol Chem       Date:  2014-10-24       Impact factor: 5.157

Review 9.  Regulation of senescence traits by MAPKs.

Authors:  Carlos Anerillas; Kotb Abdelmohsen; Myriam Gorospe
Journal:  Geroscience       Date:  2020-04-16       Impact factor: 7.713

Review 10.  Emerging roles of the p38 MAPK and PI3K/AKT/mTOR pathways in oncogene-induced senescence.

Authors:  Yingxi Xu; Na Li; Rong Xiang; Peiqing Sun
Journal:  Trends Biochem Sci       Date:  2014-05-09       Impact factor: 13.807

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.